To explore the role of BRCA1 gene in the response to chemotherapy, we analyzed the effect of BRCA1 suppression by BRCA1-specific siRNA on the sensitivity to anti-cancer agents such as cisplatin and paclitaxel, as well as to ionizing radiation in ovarian cancer cells with different p53 status. This evidence concerns the gene TP53 and ovarian carcinoma.